The Paris Bourse ended up 0.76% on Monday, a few points off its closing record, thus overcoming short-term concerns related to Omicron.
The flagship CAC 40 index gained 53.81 7,140.39 points, with a famlique trading volume of just over 1.7 billion euros.
After a cautious start to the session, the Parisian odds consolidated their rise in the afternoon, approaching a few dozen points from their records (7,156.85 points at the close and 7,183.08 points in session, both reached mid -November).
We often see at the end of the year: movements that are a little exaggerated for lack of liquidity, explains AFP Florence Barjou, investment manager of Lyxor AM.
Friday, the CAC 40 had closed its half-year New Year’s Eve on a decline of 0.28%, but recording an increase of 2.31% over the week.
The market still clearly wants to see the cup half full rather than half empty in the face of the Omicron variant of the Covid-19 which is spreading very quickly across the world, adds Florence Barjou.
While new British studies have indicated that Omicron will lead to fewer hospitalizations, its spread raises fears of restrictions or organizations in short-term savings.
In France, the executive met on Monday to decide on possible new restrictive measures in the face of the meteoric growth of Omicron and to accelerate the transformation of the health past into a vaccine pass. A press conference by Prime Minister Jean Castex and Minister of Health Olivier Vran is scheduled for 7.15pm.
But the markets are saying that this may be the last big wave and are surely reassured by the prospects for herd immunity, the treatments, the vaccinations and also the fact that even if the cases progress, the mortality, in particular that related to it. Omicron remains relatively contained, continues Florence Barjou.
Eurofins profits from the rise in tests
More than 100,000 new cases were recorded on Saturday in France, a figure unknown since the start of the pandemic, with also records of tests carried out.
save on fees and earn up to 350 € thanks our life insurance comparison
The French glove from Eurofins Scientific analysis laboratories, whose activity is driven by Covid-19 and screening tests, ended up 1.82% to 110.68 euros. The French laboratory Sanofi took 0.81% 88.57 euros and the supplier of materials for the biopharmaceutical sector Sartorius Stedim Biotech 1.71% 475.70 euros.
Luxury always in shape
Heavyweight of the CAC 40, the values of luxury did not fall on Monday: Kering recorded an increase of 1.75% 699euros and LVMH of 1.24% 726.30euros. Hermes’ progress was more timid (+0.49, 1538euros).
Having major luxury stocks which have performed very well has helped the CAC, which has now grown by more than 28% over the year as a whole, reminds Florence Barjou.